Protein binding of carbamazepine in epileptic patients. 1982

L M Lawless, and H J DeMonaco, and L R Muido

The degree of protein binding of carbamazepine was evaluated in 45 mentally retarded epileptic patients. Although the mean percent unbound carbamazepine agreed with that obtained elsewhere, a wide interpatient variability was noted. There was a good correlation between unbound carbamazepine and total carbamazepine serum concentrations. The results of this study indicate that the total carbamazepine serum concentration must be interpreted with caution, and the unbound fraction may be a more appropriate therapeutic measure.

UI MeSH Term Description Entries
D008607 Intellectual Disability Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28) Disability, Intellectual,Idiocy,Mental Retardation,Retardation, Mental,Deficiency, Mental,Intellectual Development Disorder,Mental Deficiency,Mental Retardation, Psychosocial,Deficiencies, Mental,Development Disorder, Intellectual,Development Disorders, Intellectual,Disabilities, Intellectual,Disorder, Intellectual Development,Disorders, Intellectual Development,Intellectual Development Disorders,Intellectual Disabilities,Mental Deficiencies,Mental Retardations, Psychosocial,Psychosocial Mental Retardation,Psychosocial Mental Retardations,Retardation, Psychosocial Mental,Retardations, Psychosocial Mental
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002220 Carbamazepine A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties. Amizepine,Carbamazepine Acetate,Carbamazepine Anhydrous,Carbamazepine Dihydrate,Carbamazepine Hydrochloride,Carbamazepine L-Tartrate (4:1),Carbamazepine Phosphate,Carbamazepine Sulfate (2:1),Carbazepin,Epitol,Finlepsin,Neurotol,Tegretol
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

L M Lawless, and H J DeMonaco, and L R Muido
August 1976, British journal of clinical pharmacology,
L M Lawless, and H J DeMonaco, and L R Muido
July 1981, British journal of clinical pharmacology,
L M Lawless, and H J DeMonaco, and L R Muido
January 1983, Methods and findings in experimental and clinical pharmacology,
L M Lawless, and H J DeMonaco, and L R Muido
July 1981, British journal of clinical pharmacology,
L M Lawless, and H J DeMonaco, and L R Muido
January 1983, Acta neurologica Scandinavica. Supplementum,
L M Lawless, and H J DeMonaco, and L R Muido
January 1977, Folia psychiatrica et neurologica japonica,
L M Lawless, and H J DeMonaco, and L R Muido
November 1978, European journal of clinical pharmacology,
L M Lawless, and H J DeMonaco, and L R Muido
January 2010, Pharmacological reports : PR,
L M Lawless, and H J DeMonaco, and L R Muido
August 1978, Journal of neurology, neurosurgery, and psychiatry,
Copied contents to your clipboard!